Why the study?
Left ventricular overload is frequent under VA-ECMO and worsens prognosis, but there is no consensus on the timing and type of left heart decompression techniques.
Does percutaneous atrioseptostomy improve 90-day survival compared to other left heart decompression techniques in patients on veno-arterial extracorporeal membrane oxygenation?
Does percutaneous atrioseptostomy improve 90-day survival compared to other left heart decompression techniques in patients on veno-arterial extracorporeal membrane oxygenation?
Percutaneous atrioseptostomy appears to be a safe and effective left heart decompression technique associated with improved 90-day survival in patients on VA-ECMO compared to other techniques.
Answers are grounded in this paper and cite their sources.
May support percutaneous atrioseptostomy for VA-ECMO decompression; hypothesis-generating and requires randomized confirmation.
Background Left ventricular overload is frequent under veno‐arterial extracorporeal membrane oxygenation, which is associated with a worsening of the prognosis of these patients. Several left heart decompression (LHD) techniques exist. However, there is no consensus on their timing and type. We aimed to describe characteristics and outcomes of patients undergoing LHD and to compare percutaneous atrioseptostomy (PA) to other LHD techniques. Methods and Results Retrospective analysis was conducted of consecutive and prospectively collected patients supported by veno‐arterial extracorporeal membrane oxygenation for refractory cardiac arrest or cardiogenic shock between January 2015 and April 2018, with a 90‐day follow‐up in our tertiary center. Patients were divided according to the presence of LHD, and then according to its type (PA versus others). Thirty‐nine percent (n=63) of our patients (n=163) required an LHD. Patients with LHD had lower left ventricular ejection fraction, more ischemic cardiomyopathy, and no drug intoxication‐associated cardiogenic shock. PA was frequently used for LHD (41% of first‐line and 57% of second‐line LHD). PA appears safe and fast to realize (6.3 [interquartile range, 5.8–10] minutes) under fluoroscopic and echocardiographic guidance, with no acute complications. PA was associated with fewer neurological complications (12% versus 38%, P =0.02), no need to insert a second LHD (0% versus 19%, P =0.04), and higher 90‐day survival compared with other techniques (42% versus 19%, log‐rank test P =0.02), despite more sepsis (96% versus 73%, P =0.02) and blood transfusions (13.5% versus 7%, P =0.01). Multivariate analysis confirms the association between PA and 90‐day survival (hazard ratio, 2.53 [1.18–5.45], P =0.019). Conclusions LHD was frequently used for patients supported with veno‐arterial extracorporeal membrane oxygenation, especially in cases of ischemic cardiomyopathy and low left ventricular ejection fraction. PA seems to be a safe and efficient LHD technique associated with greater mid‐term survival justifying the pursuit of research on this topic.
No takes yet. Share an insight, caveat, or question.
Delmas et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: